Liposuction for protease-inhibitorassociated lipodystrophy
1999; Elsevier BV; Volume: 353; Issue: 9160 Linguagem: Inglês
10.1016/s0140-6736(99)01172-1
ISSN1474-547X
AutoresSamuel Ponce‐de‐León, Martín Iglesias, Joel Ceballos, Luis Ostrosky‐Zeichner,
Tópico(s)HIV Research and Treatment
ResumoPeripheral lipodystrophy, hyperlipidaemia, and insulin resistance has been reported as a side-effect of proteaseinhibitor treatment for HIV-1 infection. 1 Viraben R Aquilina C Indinavir-associated lipodystrophy. AIDS. 1998; 12: 37-39 Crossref Scopus (236) Google Scholar , 2 Carr A Samaras K Burton S et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998; 12: 51-58 Crossref PubMed Scopus (2203) Google Scholar , 3 Walli R Herfort O Michl GM et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS. 1998; 12: 167-173 Crossref PubMed Scopus (505) Google Scholar We report a man who developed lipodystrophy when treated with saquinavir and nelfinavir who had liposuction.
Referência(s)